US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.4346 +0.0156 (+3.72%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
HeartBeam, Inc. Letter to Shareholders
From HeartBeam, Inc.
Via Business Wire
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Heart Attack Detection Program, Extends Cash Runway Into 2027
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript ↗
HeartBeam (NASDAQ:BEAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts... 
Via Benzinga
Topics Earnings
News headline image
HeartBeam Reports Second Quarter 2026 Results
From HeartBeam, Inc.
Via Business Wire
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Sets Aug. 13 Call To Review Q2 Results and Strategy
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Patent Expands Cardiac Monitoring Platform With Heart Failure and Structural Heart Disease Capabilities
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
Via Investor Brand Network
Topics Intellectual Property
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection
Via Investor Brand Network
Topics Death
News headline image
Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks ↗
Insiders are betting big on three stocks. Board members, CEOs, and CFOs are among the buyers, signalling confidene in their fundamentals. 
Via MarketBeat
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam (BEAT) Q1 2026 Earnings Transcript ↗
HeartBeam (BEAT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
HeartBeam Reports First Quarter 2026 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions
Via Investor Brand Network
Topics Death
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates
Via Investor Brand Network
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Collaborates to Advance Next-Gen ECG Solutions
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >